new video loaded: J&J Vaccine Pause Will Have Limited Impact, White House Says
J&J Vaccine Pause Will Have Limited Impact, White House Says
Jeffrey D. Zients, the White House Covid-19 response coordinator, said Tuesday that pausing the use of Johnson & Johnson’s coronavirus vaccine would not impact the administration’s vaccination goals.
“Let me start by saying that this announcement will not have a significant impact on our vaccination program. The J&J vaccine makes up less than 5 percent of the more than 190 million recorded shots in arms in the United States to date. So we have more than enough supply of Pfizer and Moderna vaccines to continue the current pace of about three million shots per day. And that puts us well on pace to meet the president’s goal of 200 million shots by his 100th day in office.” “Questions that comes up already, rather frequently. Does this have anything to do with the efficacy of the vaccine? So someone who maybe had it a month or two ago would say, ‘What does this mean for me?’” It really doesn’t mean anything. You’re OK, because if you look at the frame, the time frame, when this occurs, it’s pretty tight — from a few days, six to 13 days from the time of the vaccination. We are totally aware that this is a very rare event. We want to get this worked out as quickly as we possibly can. And that’s why you see the word pause. In other words, you want to hold off for a bit, and very well may go back to that, maybe with some conditions or maybe not. But we want to leave that up to the F.D.A. and the C.D.C. to investigate this carefully.”
Recent episodes in Coronavirus Pandemic: Latest Updates